Good Publication Practice (GPP) guidelines for company-sponsored biomedical research from the point of view of the diverse authors involved in its publication

Leslie Citrome,Lisa M DeTora,Dikran Toroser,Angela Sykes,Trevor Lane,Eline Hanekamp,Laura Dormer,Faith DiBiasi,Lise Baltzer,Lisa M. DeTora
DOI: https://doi.org/10.1080/03007995.2024.2320298
2024-03-06
Current Medical Research and Opinion
Abstract:Less than two years ago, the 2022 update to the Good Publication Practice (GPP) guidelines for company-sponsored biomedical research was published in the Annals of Internal Medicine Citation 1 . This new version of GPP has generated correspondence Citation 2–4 , further commentary Citation 5 , Citation 6 , and has been translated into Chinese and Japanese (see https://www.ismpp.org/gpp-2022). The first version of GPP appeared in 2003 in the pages of Current Medical Research & Opinion Citation 7 , with subsequent iterations Citation 1 , Citation 8 , Citation 9 created under the auspices of the International Society for Medical Publication Professionals (ISMPP), a not-for-profit organization founded in 2005 Citation 10 .
medicine, general & internal, research & experimental
What problem does this paper attempt to address?